Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
53.60
+0.86 (1.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.97 billion as of December 20, 2024. Its market cap has increased by 122.26% in one year.
Market Cap
4.97B
Enterprise Value
4.16B
1-Year Change
122.26%
Ranking
Category
Stock Price
$53.60
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.97B, an increase of 781.45%. That is a compound annual growth rate of 40.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.38B |
| Corcept Therapeutics | 5.36B |
| RadNet | 5.28B |
| Tempus AI | 5.20B |
| BridgeBio Pharma | 4.95B |
| Alkermes | 4.85B |
| Krystal Biotech | 4.63B |
| Viking Therapeutics | 4.62B |